losartan has been researched along with mycophenolic acid in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (70.59) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Antunes, GR; DE Lourdes Noronha, I; DE Oliveira, IB; Fujihara, CK; Malheiros, DMAC; Zatz, R | 1 |
| Azzollini, N; Benigni, A; Gagliardini, E; Marchetti, G; Mister, M; Noris, M; Perico, N; Pezzotta, A; Remuzzi, G | 1 |
| Ahn, HJ; Bang, BK; Cha, JH; Jung, JY; Kim, J; Kim, WY; Kim, YS; Li, C; Yang, CW; Yoon, SA | 1 |
| Bräsen, JH; Budde, K; Dragun, D; Fritsche, L; Luft, FC; Neumayer, HH; Schönemann, C; Wallukat, G | 1 |
| Casarini, DE; Cavaglieri, Rde C; Dellê, H; Dominguez, WV; Graciano, ML; Malheiros, DM; Noronha, IL | 1 |
| Abassi, Z; Assady, S; Khankin, E; Kositch, Z; Lewin, M; Nakhoul, F; Ramadan, R; Yaccob, A | 1 |
| Li, Z; Quiroz, Y; Rodríguez-Iturbe, B; Shahkarami, A; Vaziri, ND | 1 |
| Allison, AC; Eugui, EM | 1 |
| Fujihara, CK; Machado, FG; Malheiros, DM; Mattar, AL; Zatz, R | 1 |
| Fujihara, CK; Malheiros, DM; Sena, CR; Ventura, BH; Vieira, JM; Zatz, R | 1 |
| Appel, G; Bay, RC; Carter, B; Cattran, D; Cerda, J; Fervenza, FC; Fischer, D; Gipson, D; Hernandez, G; Hogg, RJ; Hurley, RM; Jennette, JC; Jung, B; Kumar, S; Sibley, R; Wyatt, RJ | 1 |
| Chen, L; Jiang, X; Lin, Z; Pei, Y; Rong, L; Tang, X | 1 |
4 review(s) available for losartan and mycophenolic acid
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; B-Lymphocytes; Dendritic Cells; Drug Synergism; Ganciclovir; Graft Rejection; Humans; Lisinopril; Losartan; Monocytes; Mycophenolic Acid; Neutrophil Infiltration; Nitric Oxide; Prodrugs; T-Lymphocytes | 2005 |
Classification and rising medication therapy in stiff skin syndrome: A case report and literature review.
Topics: Child, Preschool; Contracture; Female; Humans; Losartan; Mycophenolic Acid; Skin Diseases, Genetic | 2022 |
1 trial(s) available for losartan and mycophenolic acid
| Article | Year |
|---|---|
Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Child; Creatinine; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Lisinopril; Losartan; Male; Middle Aged; Mycophenolic Acid; Proteinuria; Remission Induction; Treatment Outcome; Young Adult | 2015 |
12 other study(ies) available for losartan and mycophenolic acid
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney.
Topics: Animals; Antihypertensive Agents; Drug Therapy, Combination; Hemodynamics; Kidney; Losartan; Male; Mycophenolic Acid; Nephrectomy; Rats; Rats, Inbred Strains; Renal Circulation; Time Factors | 2000 |
Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft.
Topics: Angiotensin Receptor Antagonists; Animals; Blood Pressure; Chronic Disease; Creatinine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Hemodynamics; Immunohistochemistry; Immunosuppressive Agents; Kidney; Kidney Transplantation; Losartan; Mycophenolic Acid; Proteinuria; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Renal Circulation; Transplantation, Homologous; Transplantation, Isogeneic | 2001 |
Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Body Weight; Chronic Disease; Cyclosporine; Drug Synergism; Fibrosis; Gene Expression; Immunosuppressive Agents; Kidney; Kidney Diseases; Losartan; Macrophages; Male; Mycophenolic Acid; Osteopontin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor.
Topics: Acute Disease; Adrenal Cortex Hormones; Angiotensin II Type 1 Receptor Blockers; Antibody Formation; Biopsy; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Imidazoles; Immunoglobulin G; Immunosuppressive Agents; Kidney Transplantation; Losartan; Major Histocompatibility Complex; Mycophenolic Acid; Pyridines; Receptor, Angiotensin, Type 1 | 2003 |
Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis.
Topics: Albumins; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Angiotensins; Animals; Antihypertensive Agents; Blood Pressure; Blotting, Western; Cathepsin D; Enalapril; Enzyme Inhibitors; Glomerulonephritis; Immunohistochemistry; Kidney; Kidney Diseases; Losartan; Male; Mycophenolic Acid; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Time Factors; Up-Regulation | 2004 |
Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Doxorubicin; Enalaprilat; Enzyme Inhibitors; Fluorescent Antibody Technique; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Kidney Glomerulus; Losartan; Male; Membrane Proteins; Mycophenolic Acid; Nephrotic Syndrome; Protein Synthesis Inhibitors; Proteinuria; Pyridines; Rats; Rats, Sprague-Dawley; Thiazepines | 2005 |
Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Immunosuppressive Agents; Losartan; Male; Mycophenolic Acid; Obesity; Rats; Rats, Zucker | 2005 |
Persistent hypertension and progressive renal injury induced by salt overload after short term nitric oxide inhibition.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Hydralazine; Hypertension; Immunohistochemistry; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Losartan; Male; Mycophenolic Acid; Nitric Oxide; Rats; Rats, Wistar; Sodium Chloride, Dietary | 2007 |
Early brief treatment with losartan plus mycophenolate mofetil provides lasting renoprotection in a renal ablation model.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Blood Pressure; Chronic Disease; Disease Models, Animal; Drug Therapy, Combination; Kidney Diseases; Losartan; Macrophages; Male; Mycophenolic Acid; Nephrectomy; Protective Agents; Rats; Rats, Inbred Strains; Time Factors | 2010 |